Patent details

Basic Information

Publication number:

EP2805731

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP141711200

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Stable formulations of polypeptides and uses thereof

French Title of Invention:

Formulations stables de polypeptides et leurs utilisations

German Title of Invention:

Stabile Formulierungen aus Polypeptiden und Verwendungen davon

SPC Number:

Dates

Filing date:

03/09/2010

Grant date:

31/10/2018

EP Publication Date:

26/11/2014

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

31/10/2018

EP B1 Publication Date:

31/10/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

03/09/2019

Expiration date:

03/09/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

24/10/2018

 

 

Name:

Ablynx N.V.

Address:

Technologiepark 21, 9052 Ghent-Zwijnaarde, Belgium (BE)

Inventor

1

Name:

Labeur, Christine

Address:

Belgium (BE)

2

Name:

De Brabandere, Veronique

Address:

Belgium (BE)

3

Name:

Brigé, Ann

Address:

Belgium (BE)

Priority

1

Priority Number:

275816 P

Priority Date:

03/09/2009

Priority Country:

United States (US)

2

Priority Number:

284502 P

Priority Date:

18/12/2009

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/00; A61K 39/395; A61K 47/02; A61K 47/26; A61K 47/14;

Publication

European Patent Bulletin

Issue number:

201844

Publication date:

31/10/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages